治疗血液透析患者维生素K缺乏症-比较甲基萘醌-7片和富含维生素K饮食的初步研究。

IF 2.1 Q2 UROLOGY & NEPHROLOGY
Katrine Aagaard Lentz, Julie Vahlgren, Ditte Hansen, Mario Plebani, Maria Fusaro, Lars Melholt Rasmussen, Jette Jakobsen, Jens Jørgen Sloth, Henrik Post Hansen, Jens Rikardt Andersen
{"title":"治疗血液透析患者维生素K缺乏症-比较甲基萘醌-7片和富含维生素K饮食的初步研究。","authors":"Katrine Aagaard Lentz,&nbsp;Julie Vahlgren,&nbsp;Ditte Hansen,&nbsp;Mario Plebani,&nbsp;Maria Fusaro,&nbsp;Lars Melholt Rasmussen,&nbsp;Jette Jakobsen,&nbsp;Jens Jørgen Sloth,&nbsp;Henrik Post Hansen,&nbsp;Jens Rikardt Andersen","doi":"10.2147/IJNRD.S365912","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Vitamin K deficiency and hence a high level of plasma dephosphorylated undercarboxylated matrix Gla protein (dp-ucMGP) is frequent in patients on hemodialysis. This group is recommended to restrict their potassium intake which often leads to restriction of vitamin K rich foods. A menaquinone-7 (MK-7) supplement has been shown to decrease dp-ucMGP, but it has yet to be examined if a vitamin K rich diet could be equally effective.</p><p><strong>Patients and methods: </strong>A prospective randomized crossover intervention trial with two arms; 6 weeks of 360 μg MK-7 tablet/day and 6 weeks of a vitamin K rich diet with a 3-week washout period in between. Participants were 10 patients in hemodialysis and the primary outcome measures were changes in dp-ucMGP, total MGP (tMGP), and undercarboxylated osteocalcin (ucOC). Furthermore, the level of potassium and phylloquinone in broccoli was determined after different durations of boiling.</p><p><strong>Results: </strong>During the MK-7 intervention the dp-ucMGP and ucOC decreased significantly compared to baseline (-0.42 [-0.93; -0.22] nmol/L (<i>p</i>=<0.01) and -1.85 [-2.91; -1.30] nmol/L (<i>p</i><0.01)), while these were unchanged during the dietary intervention (0.03 [-0.64; 0.37] nmol/L (<i>p</i>=1.00) and 0.30 [-1.71; 1.41] nmol/L (<i>p</i>=0.77)). Between the two interventions there was a greater decrease in ucOC (<i>p</i>=0.02) during the MK-7 compared to the dietary period. No significant changes in the total MGP levels were found in any of the periods. The retention of potassium following boiling for 2 minutes and 8 minutes was 76% and 49%, respectively, while for phylloquinone the retention was 92%, and independent of duration of boiling.</p><p><strong>Conclusion: </strong>A daily MK-7 supplement for 6 weeks lowered dp-ucMGP and ucOC significantly, while a vitamin K rich diet was not able to induce any significant effect. Boiled broccoli maintains a reasonable content of phylloquinone while potassium is extracted and is a reasonable source of phylloquinone for patients on hemodialysis.</p>","PeriodicalId":14181,"journal":{"name":"International Journal of Nephrology and Renovascular Disease","volume":null,"pages":null},"PeriodicalIF":2.1000,"publicationDate":"2022-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7c/64/ijnrd-15-267.PMC9586167.pdf","citationCount":"0","resultStr":"{\"title\":\"Treatment of Vitamin K Deficiency in Hemodialysis Patients - A Pilot Study Comparing Menaquinone-7 Tablets and a Vitamin K Rich Diet.\",\"authors\":\"Katrine Aagaard Lentz,&nbsp;Julie Vahlgren,&nbsp;Ditte Hansen,&nbsp;Mario Plebani,&nbsp;Maria Fusaro,&nbsp;Lars Melholt Rasmussen,&nbsp;Jette Jakobsen,&nbsp;Jens Jørgen Sloth,&nbsp;Henrik Post Hansen,&nbsp;Jens Rikardt Andersen\",\"doi\":\"10.2147/IJNRD.S365912\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>Vitamin K deficiency and hence a high level of plasma dephosphorylated undercarboxylated matrix Gla protein (dp-ucMGP) is frequent in patients on hemodialysis. This group is recommended to restrict their potassium intake which often leads to restriction of vitamin K rich foods. A menaquinone-7 (MK-7) supplement has been shown to decrease dp-ucMGP, but it has yet to be examined if a vitamin K rich diet could be equally effective.</p><p><strong>Patients and methods: </strong>A prospective randomized crossover intervention trial with two arms; 6 weeks of 360 μg MK-7 tablet/day and 6 weeks of a vitamin K rich diet with a 3-week washout period in between. Participants were 10 patients in hemodialysis and the primary outcome measures were changes in dp-ucMGP, total MGP (tMGP), and undercarboxylated osteocalcin (ucOC). Furthermore, the level of potassium and phylloquinone in broccoli was determined after different durations of boiling.</p><p><strong>Results: </strong>During the MK-7 intervention the dp-ucMGP and ucOC decreased significantly compared to baseline (-0.42 [-0.93; -0.22] nmol/L (<i>p</i>=<0.01) and -1.85 [-2.91; -1.30] nmol/L (<i>p</i><0.01)), while these were unchanged during the dietary intervention (0.03 [-0.64; 0.37] nmol/L (<i>p</i>=1.00) and 0.30 [-1.71; 1.41] nmol/L (<i>p</i>=0.77)). Between the two interventions there was a greater decrease in ucOC (<i>p</i>=0.02) during the MK-7 compared to the dietary period. No significant changes in the total MGP levels were found in any of the periods. The retention of potassium following boiling for 2 minutes and 8 minutes was 76% and 49%, respectively, while for phylloquinone the retention was 92%, and independent of duration of boiling.</p><p><strong>Conclusion: </strong>A daily MK-7 supplement for 6 weeks lowered dp-ucMGP and ucOC significantly, while a vitamin K rich diet was not able to induce any significant effect. Boiled broccoli maintains a reasonable content of phylloquinone while potassium is extracted and is a reasonable source of phylloquinone for patients on hemodialysis.</p>\",\"PeriodicalId\":14181,\"journal\":{\"name\":\"International Journal of Nephrology and Renovascular Disease\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2022-10-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7c/64/ijnrd-15-267.PMC9586167.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Nephrology and Renovascular Disease\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2147/IJNRD.S365912\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Nephrology and Renovascular Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/IJNRD.S365912","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:在血液透析患者中,维生素K缺乏症和血浆高水平去磷酸化羧化基质Gla蛋白(dp-ucMGP)是常见的。建议这一群体限制钾的摄入量,这通常会导致他们限制摄入富含维生素K的食物。甲基萘醌-7 (MK-7)补充剂已被证明可以降低dp-ucMGP,但还有待检验富含维生素K的饮食是否同样有效。患者和方法:两组前瞻性随机交叉干预试验;6周服用360 μg MK-7片/天,6周服用富含维生素K的饮食,中间有3周的洗脱期。参与者是10名血液透析患者,主要结局指标是dp-ucMGP、总MGP (tMGP)和欠羧化骨钙素(ucOC)的变化。此外,还测定了不同煮沸时间后西兰花中钾和叶绿醌的含量。结果:在MK-7干预期间,dp-ucMGP和ucOC与基线相比显著下降(-0.42 [-0.93;-0.22] nmol/L (p=pp=1.00)和0.30 [-1.71;1.41] nmol/L (p=0.77))。在两种干预之间,MK-7期间与饮食期间相比,ucOC的下降幅度更大(p=0.02)。在任何时期,MGP总水平均未发现显著变化。煮沸2分钟和8分钟后,钾的保留率分别为76%和49%,叶绿醌的保留率为92%,且与煮沸时间无关。结论:每天补充MK-7,持续6周,可显著降低dp-ucMGP和ucOC,而富含维生素K的饮食不能诱导任何显著效果。煮熟的西兰花在提取钾的同时保持了叶绿醌的合理含量,是血液透析患者叶绿醌的合理来源。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Treatment of Vitamin K Deficiency in Hemodialysis Patients - A Pilot Study Comparing Menaquinone-7 Tablets and a Vitamin K Rich Diet.

Treatment of Vitamin K Deficiency in Hemodialysis Patients - A Pilot Study Comparing Menaquinone-7 Tablets and a Vitamin K Rich Diet.

Treatment of Vitamin K Deficiency in Hemodialysis Patients - A Pilot Study Comparing Menaquinone-7 Tablets and a Vitamin K Rich Diet.

Purpose: Vitamin K deficiency and hence a high level of plasma dephosphorylated undercarboxylated matrix Gla protein (dp-ucMGP) is frequent in patients on hemodialysis. This group is recommended to restrict their potassium intake which often leads to restriction of vitamin K rich foods. A menaquinone-7 (MK-7) supplement has been shown to decrease dp-ucMGP, but it has yet to be examined if a vitamin K rich diet could be equally effective.

Patients and methods: A prospective randomized crossover intervention trial with two arms; 6 weeks of 360 μg MK-7 tablet/day and 6 weeks of a vitamin K rich diet with a 3-week washout period in between. Participants were 10 patients in hemodialysis and the primary outcome measures were changes in dp-ucMGP, total MGP (tMGP), and undercarboxylated osteocalcin (ucOC). Furthermore, the level of potassium and phylloquinone in broccoli was determined after different durations of boiling.

Results: During the MK-7 intervention the dp-ucMGP and ucOC decreased significantly compared to baseline (-0.42 [-0.93; -0.22] nmol/L (p=<0.01) and -1.85 [-2.91; -1.30] nmol/L (p<0.01)), while these were unchanged during the dietary intervention (0.03 [-0.64; 0.37] nmol/L (p=1.00) and 0.30 [-1.71; 1.41] nmol/L (p=0.77)). Between the two interventions there was a greater decrease in ucOC (p=0.02) during the MK-7 compared to the dietary period. No significant changes in the total MGP levels were found in any of the periods. The retention of potassium following boiling for 2 minutes and 8 minutes was 76% and 49%, respectively, while for phylloquinone the retention was 92%, and independent of duration of boiling.

Conclusion: A daily MK-7 supplement for 6 weeks lowered dp-ucMGP and ucOC significantly, while a vitamin K rich diet was not able to induce any significant effect. Boiled broccoli maintains a reasonable content of phylloquinone while potassium is extracted and is a reasonable source of phylloquinone for patients on hemodialysis.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.90
自引率
5.00%
发文量
40
审稿时长
16 weeks
期刊介绍: International Journal of Nephrology and Renovascular Disease is an international, peer-reviewed, open-access journal focusing on the pathophysiology of the kidney and vascular supply. Epidemiology, screening, diagnosis, and treatment interventions are covered as well as basic science, biochemical and immunological studies. In particular, emphasis will be given to: -Chronic kidney disease- Complications of renovascular disease- Imaging techniques- Renal hypertension- Renal cancer- Treatment including pharmacological and transplantation- Dialysis and treatment of complications of dialysis and renal disease- Quality of Life- Patient satisfaction and preference- Health economic evaluations. The journal welcomes submitted papers covering original research, basic science, clinical studies, reviews & evaluations, guidelines, expert opinion and commentary, case reports and extended reports. The main focus of the journal will be to publish research and clinical results in humans but preclinical, animal and in vitro studies will be published where they shed light on disease processes and potential new therapies and interventions.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信